Huntington National Bank Sells 2,102 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Huntington National Bank trimmed its position in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 103,918 shares of the company’s stock after selling 2,102 shares during the period. Huntington National Bank’s holdings in Church & Dwight were worth $10,881,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. YANKCOM Partnership purchased a new stake in shares of Church & Dwight during the 4th quarter valued at approximately $25,000. Versant Capital Management Inc lifted its position in shares of Church & Dwight by 224.4% during the fourth quarter. Versant Capital Management Inc now owns 266 shares of the company’s stock worth $28,000 after acquiring an additional 184 shares in the last quarter. Bank of Jackson Hole Trust purchased a new stake in shares of Church & Dwight during the fourth quarter worth $43,000. Golden State Wealth Management LLC bought a new position in shares of Church & Dwight in the fourth quarter worth $51,000. Finally, Whittier Trust Co. of Nevada Inc. grew its position in shares of Church & Dwight by 50.5% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 575 shares of the company’s stock valued at $60,000 after purchasing an additional 193 shares in the last quarter. 86.60% of the stock is owned by hedge funds and other institutional investors.

Church & Dwight Stock Performance

NYSE:CHD opened at $108.29 on Thursday. The company has a market capitalization of $26.65 billion, a price-to-earnings ratio of 45.69, a PEG ratio of 3.32 and a beta of 0.57. The business has a 50 day moving average of $107.81 and a 200 day moving average of $106.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.70 and a quick ratio of 1.24. Church & Dwight Co., Inc. has a 1-year low of $96.35 and a 1-year high of $116.46.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the previous year, the business posted $0.65 earnings per share. On average, sell-side analysts predict that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Friday, February 14th were issued a dividend of $0.295 per share. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend was Friday, February 14th. Church & Dwight’s dividend payout ratio is currently 49.79%.

Analysts Set New Price Targets

Several research analysts have commented on the company. JPMorgan Chase & Co. cut their target price on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating for the company in a research note on Friday, February 21st. Barclays boosted their price objective on shares of Church & Dwight from $93.00 to $97.00 and gave the company an “underweight” rating in a research note on Thursday, March 27th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $105.00 target price on shares of Church & Dwight in a research note on Monday, February 3rd. Wells Fargo & Company boosted their price target on shares of Church & Dwight from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Truist Financial lifted their price objective on Church & Dwight from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Church & Dwight has a consensus rating of “Hold” and a consensus price target of $112.13.

Insider Buying and Selling at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $115.98, for a total value of $6,322,069.80. Following the completion of the sale, the executive vice president now owns 10,497 shares in the company, valued at approximately $1,217,442.06. This trade represents a 83.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Rene Hemsey sold 11,060 shares of the business’s stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total value of $1,216,378.80. Following the transaction, the executive vice president now directly owns 6,437 shares in the company, valued at $707,941.26. This trade represents a 63.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 65,570 shares of company stock valued at $7,538,449 in the last quarter. Company insiders own 2.00% of the company’s stock.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.